港股异动 | 科伦博泰生物-B(06990)盘中涨超6%创上市新高 将于SABCS大会展示核心产品SKB264研究结果
科伦博泰生物-B(06990)盘中涨超6%，高见100.7港元，创上市新高。截至发稿，涨2.91%，报97.25港元，成交额1749.35万港元。
消息面上，科伦博泰生物公布，将在12月5至9日举行2023年圣安东尼奥乳腺癌研讨会(SABCS)上的poster spotlight环节，展示创新TROP2-ADC(SKB264，亦称为MK-2870)用于既往接受过治疗的转移性三阴性乳腺癌(mTNBC)患者的2期扩展队列的最新疗效及安全性结果。
此外，公司日前公布，公司的主要产品A400(在转染过程中重排(RET)小分子激酶抑制剂项目，亦称为KL590586或EP0031)获得了美国食品药品监督管理局(FDA)授予的孤儿药资格认定，用于治疗RET融合阳性实体瘤。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.